Canadian Suit Offers Disclosure Lesson For US Cannabis Cos.
July 7, 2025
A Canadian class action asserting that Aurora Cannabis failed to warn consumers about the risk of developing cannabinoid hyperemesis syndrome may spawn copycat filings in the U.S., and is a cautionary tale for cannabis and hemp industries to prioritize risk disclosure, says Ian Stewart at Wilson Elser.
Search
RECENT PRESS RELEASES
Related Post